CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Azithromycin IVdrug
Likely dose
Azithromycin IV 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01784770
NCT01784770N/ACompleted
CompareCT.gov

Zithromac Iv Special Investigation For Legionella Infection.

Pfizer·observational·Posted Feb 6, 2013·Updated Nov 30, 2017

In Brief

An observational study evaluating Azithromycin IV for Legionnaires' Disease and Legionella Pneumophila Infections. Completed, enrolled 21 participants.

Detailed Summary

To collect retrospectively the efficacy and safety information of azithromycin IV on patients with Legionnaires' disease related to their appropriate use in daily practice.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLegionnaires' Disease, Legionella Pneumophila Infections
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 6, 2013
Enrollment StartMar 27, 2013
Primary CompletionJul 29, 2016
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 13.4 years ago

Interventions

Azithromycin IVdrug

The recommended dose of ZITHROMAC (azithromycin for injection) for the treatment of adult patients with community-acquired pneumonia due to the indicated organisms is: 500 mg as a single daily dose by the intravenous route for at least two days. Intravenous therapy should be followed by azithromycin by the oral route at a single, daily dose of 500 mg, administered as two 250-mg tablets to complete a 7- to 10-day course of therapy. The recommended dose of ZITHROMAC (azithromycin for injection) for the treatment of adult patients with pelvic inflammatory disease due to the indicated organisms is: 500 mg as a single daily dose by the intravenous route for one or two days. Intravenous therapy should be followed by azithromycin by the oral route at a single, daily dose of 250 mg to complete a 7-day course of therapy.